Biotin immunoassay interference: A UK-based prevalence study.

Anna Sanders Rousseau GamaH AshbyP Mohammed

Published in: Annals of clinical biochemistry (2020)

These data indicate that the probability of biotin immunoassay interference in our patient population is extremely low, with the exception of assays reporting the lowest interference thresholds (e.g. Ortho Troponin I assay [threshold ≥2.5 µg/L]).

Keyphrases

high throughput
sensitive detection
risk factors
case report
electronic health record
big data
emergency department
adverse drug
machine learning
deep learning